The FDA laboratory on HIV sequence analysis and biologic characterization (co-receptor usage) is conducting studies to characterize viruses/plasma from blood bank and diagnostic settings in Cameroon. New strains or plasma will be contributed to the NIAID for the development of a variant panel that may be useful in vaccine studies and to the manufacturers of HIV blood screening, diagnostic and monitoring assays.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Zip Code